Spots Global Cancer Trial Database for Investigator's Initiated Phase II Study for Pancreatic Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Investigator's Initiated Phase II Study for Pancreatic Cancer Patients
Official Title:
Study ID: NCT01659502
Conditions
Pancreatic Cancer
Interventions
TL-118
Study Description
Brief Summary: The purpose of this study is to evaluate the efficacy, safety and tolerability of TL-118 alone or in combination with pancreatic cancer chemotherapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hadassah Medical Center, Jerusalem, , Israel
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
